id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1994-N-0362-0002,FDA,FDA-1994-N-0362,Drug Products Containing Quinine for the Treatment and/or Prevention of Malaria for Over-The-Counter Human Use,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-04-06T04:00:00Z,2012,4,2012-04-06T04:00:00Z,1995-07-04T03:59:59Z,2012-04-06T15:38:17Z,95-9701,0,0,0900006480508547
FDA-1994-N-0362-0005,FDA,FDA-1994-N-0362,"FDA/ONPDP Response to Joseph Kiraly, M.D. - Letter",Other,Letter(s),2012-04-06T04:00:00Z,2012,4,2012-04-06T04:00:00Z,,2012-04-06T16:14:41Z,,0,0,09000064806a4312
FDA-1994-N-0362-0001,FDA,FDA-1994-N-0362,Drug Products Containing Quinine for the Treatment and/or Prevention of Malaria for Over-the-Counter Human Use,Notice,Notice of Final Rule,2012-04-04T04:00:00Z,2012,4,2012-04-04T04:00:00Z,1995-07-04T03:59:59Z,2012-04-04T12:50:55Z,98-7186,0,0,0900006480508549